ISSN: 1522-4821

Journal international sur la santé mentale d'urgence et la résilience humaine

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Recommendations for Inpatient Psychiatric Treatment for Suicidal Adolescents

Kimberly H. McManama O’Brien

There is a great need for research that would provide empirical support for interventions and approaches to acute care that reduce the morbidity and mortality of suicide-related thoughts and behaviors in adolescents (Corcoran et al., 2011). The treatment adolescents currently receive on inpatient psychiatric units is sub-par, and this is not due to the experience and skills of clinicians, but rather, the larger system of psychiatric care in the United States. When parents agree to psychiatric hospitalization for their adolescents, they typically believe their adolescents will receive treatment at these units. However, rather than receive the active treatment they need on these units, they are essentially held there until they are “stable enough” to receive community-based residential treatment or outpatient treatment. This is an extremely ineffective way to treat adolescents with active suiciderelated thoughts and behaviors. Why not take advantage of the time when they are in crisis to deliver evidence-based treatments in brief formats but intensive doses? Currently, there are no evidence-based psychiatric inpatient treatments that have been found to reduce the frequency of suicide-related behaviors or suicide attempts subsequent to discharge (Knesper, 2010). Therefore, there is a critical need for the development and testing of brief, but intensive, treatments that can be delivered in acute psychiatric care settings (Knesper, 2010).